Breaking down barriers: aurora cannabis eases patient access to high quality medical cannabis products in australia

Nasdaq | tsx: acb largest global medical cannabis company operating in nationally regulated markets, aurora removes concession card requirements to access indimed products in australia edmonton, ab , feb. 14, 2025 /prnewswire/ - aurora cannabis inc. (the "company" or "aurora")  (nasdaq: acb) (tsx: acb), the canadian-based leading global medical cannabis company, in conjunction with medreleaf australia, recently removed the concession card requirement for patients to access medical cannabis products under the company's indimed brand. by removing this eligibility barrier, any patient in australia can now be prescribed indimed products, providing greater patient access to high quality medical cannabis options.
ACB Ratings Summary
ACB Quant Ranking